A quality improvement approach to optimizing medication use in the neonatal intensive care unit

Clinics in Perinatology
Dan L Ellsbury, Robert Ursprung

Abstract

Despite many years of heavy use in premature and critically ill newborns, surprisingly few medications have been rigorously tested in neonatal multicenter randomized clinical trials. Little is known about the pharmacology of these drugs at various birth weights, gestational ages, and chronologic ages. This article describes a quality improvement approach to evaluating and improving neonatal intensive care unit (NICU) medication use, with an emphasis on adaptation of drug use to the specific clinical NICU context and use of system-based changes to minimize harm and maximize clinical benefit.

References

Dec 1, 1992·The Journal of Pediatrics·P E PutnamR M Stowe
Jul 1, 1985·American Journal of Diseases of Children·C BrouardJ P Relier
Jan 19, 1999·JAMA : the Journal of the American Medical Association·L C LevitonJ M Raczynski
Mar 10, 2001·The Journal of Pediatrics·A L Kimball, D P Carlton
Jun 30, 2001·The New England Journal of Medicine·B SchmidtUNKNOWN Trial of Indomethacin Prophylaxis in Preterms Investigators
Oct 19, 2001·American Journal of Perinatology·A J VachharajaniB A Paes
Jan 31, 2003·Journal of Perinatology : Official Journal of the California Perinatal Association·Alex F Robertson
Apr 4, 2003·Journal of Perinatology : Official Journal of the California Perinatal Association·Alex F Robertson
May 7, 2003·Journal of Perinatology : Official Journal of the California Perinatal Association·Alex F Robertson
Nov 19, 2003·Joint Commission Journal on Quality and Safety·Paul B BataldenJulie J Mohr
Sep 25, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Nicte I Mejia, Joseph Jankovic
Nov 3, 2005·Pediatrics·Juliann M Di FioreRichard J Martin
Jan 5, 2006·Pediatrics·Ronnie GuilletUNKNOWN National Institute of Child Health and Human Development Neonatal Research Network
Jan 7, 2006·Pediatrics·Daniel K BenjaminUNKNOWN National Institute of Child Health and Human Development Neonatal Research Network
Jul 21, 2006·The Cochrane Database of Systematic Reviews·A Ohlsson, S M Aher
Aug 3, 2006·Pediatrics·C Michael CottenUNKNOWN National Institute for Child Health and Human Development Neonatal Research Network
Oct 20, 2006·Clinical Pharmacokinetics·Imke H BartelinkJohn N van den Anker
Oct 12, 2007·Paediatric Drugs·Benito Almirante, Dolors Rodríguez
Feb 7, 2008·The Journal of Clinical Endocrinology and Metabolism·Brian A SwigloVictor M Montori
Feb 15, 2008·The New England Journal of Medicine·Colin J MorleyUNKNOWN COIN Trial Investigators
Apr 5, 2008·Acta Clinica Belgica·K AllegaertJ de Hoon
Jul 1, 2008·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Kevin K SukElba Fayard
Jun 23, 2009·The Journal of Pediatrics·Eva Wheatley, Kathleen A Kennedy
Sep 24, 2009·The Journal of Pediatrics·Reese H Clark, Alan R Spitzer
Nov 6, 2009·Alimentary Pharmacology & Therapeutics·A S Rao, M Camilleri
Apr 7, 2010·Clinics in Perinatology·Dan L Ellsbury
Apr 7, 2010·Clinics in Perinatology·Dan L Ellsbury, Robert Ursprung
Apr 7, 2010·Clinics in Perinatology·Robert Ursprung, James Gray
May 18, 2010·The New England Journal of Medicine·UNKNOWN SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research NetworkRosemary D Higgins
May 18, 2010·The New England Journal of Medicine·UNKNOWN SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research NetworkRosemary D Higgins
Jul 9, 2010·The Cochrane Database of Systematic Reviews·Peter W FowlieWilliam McGuire

❮ Previous
Next ❯

Citations

Jul 11, 2014·Journal of Perinatology : Official Journal of the California Perinatal Association·A L PatelJ M Silvestri
Nov 13, 2015·Journal of Perinatology : Official Journal of the California Perinatal Association·P V GordonA Spitzer
Apr 3, 2015·International Journal of Clinical Pharmacy·Adriana Cristina de Souza GonçalvesMaria Cândida Ferrarez Bouzada
Jul 9, 2016·Early Human Development·Andrew RomaineUNKNOWN Best Pharmaceuticals for Children Act – Pediatric Trials Network
Feb 14, 2018·Neonatal Network : NN·Sara E Rostas, Christopher McPherson
Sep 17, 2014·Expert Review of Clinical Pharmacology·Daniel B HawcuttMark A Turner
Mar 26, 2015·Journal of Pediatric Gastroenterology and Nutrition·Jessica E EricsonUNKNOWN Best Pharmaceuticals for Children Act–Pediatric Trials Network Administrative Core Committee
Sep 12, 2014·PloS One·Frederic LegrandEvelyne Jacqz-Aigrain

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Advances in Neonatal Care : Official Journal of the National Association of Neonatal Nurses
Catherine L Witt
Archives of Disease in Childhood. Fetal and Neonatal Edition
P Brian Smith, Daniel K Benjamin
© 2022 Meta ULC. All rights reserved